Fujian Cosunter Pharmaceutical Co., Ltd. (SHE:300436)
China
· Delayed Price · Currency is CNY 116.81
+9.95 (9.31%)
Apr 29, 2026, 3:07 PM CST
SHE:300436 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Net Income | -239.27 | -241.83 | -156.3 | -348.59 | -127.4 | -34.89 | Upgrade
|
| Depreciation & Amortization | 93.12 | 93.12 | 95.1 | 72.14 | 58.6 | 51.98 | Upgrade
|
| Other Amortization | 5.91 | 5.91 | 6.2 | 5.35 | 3.16 | 1.09 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.01 | -0.01 | -0.01 | 0.02 | - | 0.31 | Upgrade
|
| Asset Writedown & Restructuring Costs | 105.12 | 105.12 | 75.15 | 8.47 | 4.72 | 3.93 | Upgrade
|
| Loss (Gain) From Sale of Investments | 3.15 | 3.15 | 11 | 61.84 | -70.52 | -26.68 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | - | - | 0.58 | - | Upgrade
|
| Other Operating Activities | 24.29 | 34.39 | 19.38 | 8.65 | -2.56 | 9.85 | Upgrade
|
| Change in Accounts Receivable | -19.11 | -19.11 | -97.71 | -75.45 | -10.98 | -8.18 | Upgrade
|
| Change in Inventory | -45.45 | -45.45 | -37.66 | -49.3 | 9.29 | -30.83 | Upgrade
|
| Change in Accounts Payable | 34.24 | 34.24 | 78.57 | 74.72 | 51.5 | 36.62 | Upgrade
|
| Change in Other Net Operating Assets | -3.36 | -3.36 | 27.03 | -2.34 | -6.66 | -1.42 | Upgrade
|
| Operating Cash Flow | -42.59 | -35.05 | 20.71 | -174.6 | -119.68 | -17.76 | Upgrade
|
| Capital Expenditures | -60.51 | -59.55 | -66.99 | -201.24 | -195.96 | -174.41 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.02 | 0.02 | 4.5 | 0.03 | 0.02 | 0.02 | Upgrade
|
| Investment in Securities | -2.55 | -2.55 | -1.06 | -9.54 | -1.57 | - | Upgrade
|
| Other Investing Activities | - | - | 17.73 | 3.34 | 0.3 | - | Upgrade
|
| Investing Cash Flow | -63.04 | -62.07 | -45.81 | -207.41 | -197.21 | -174.38 | Upgrade
|
| Long-Term Debt Issued | - | 320.5 | 350.8 | 402.06 | 372.2 | 152.33 | Upgrade
|
| Long-Term Debt Repaid | - | -327.15 | -367.84 | -254.99 | -248.68 | -193.01 | Upgrade
|
| Net Debt Issued (Repaid) | 20.8 | -6.65 | -17.04 | 147.07 | 123.52 | -40.68 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 15.3 | 503.89 | Upgrade
|
| Common Dividends Paid | -15.24 | -15.36 | -17.42 | -17.4 | -10.35 | -9.17 | Upgrade
|
| Other Financing Activities | 178.91 | 181.91 | - | 220.05 | 34.07 | -8.46 | Upgrade
|
| Financing Cash Flow | 184.47 | 159.9 | -34.46 | 349.71 | 162.53 | 445.58 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0 | -0 | 0 | 0 | -0.01 | - | Upgrade
|
| Net Cash Flow | 78.84 | 62.78 | -59.56 | -32.29 | -154.36 | 253.43 | Upgrade
|
| Free Cash Flow | -103.1 | -94.6 | -46.28 | -375.83 | -315.64 | -192.17 | Upgrade
|
| Free Cash Flow Margin | -24.71% | -22.72% | -10.48% | -88.91% | -81.82% | -51.88% | Upgrade
|
| Free Cash Flow Per Share | -0.65 | -0.59 | -0.29 | -2.36 | -1.98 | -1.29 | Upgrade
|
| Cash Income Tax Paid | 58.37 | 61.16 | 59.61 | 54.22 | 48.37 | 31.83 | Upgrade
|
| Levered Free Cash Flow | -44.69 | -62.77 | -114.47 | -244.16 | -261.28 | -215.43 | Upgrade
|
| Unlevered Free Cash Flow | -44.69 | -62.77 | -92.25 | -222.27 | -254.66 | -209.72 | Upgrade
|
| Change in Working Capital | -34.91 | -34.91 | -29.8 | 17.52 | 13.75 | -23.36 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.